Erik Kronvall
1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A National Cohort with Aneurysmal Subarachnoid Hemorrhage—Patient Characteristics, Choice of Treatment, Clinical Outcome, and Factors of Prognostic Importance
(
- Contribution to journal › Article
- 2023
-
Mark
Adverse events associated with microsurgial treatment for ruptured intracerebral aneurysms : A prospective nationwide study on subarachnoid haemorrhage in Sweden
(
- Contribution to journal › Article
-
Mark
The impact of previous health on the mortality after aneurysmal subarachnoid hemorrhage : analysis of a prospective Swedish multicenter study
(
- Contribution to journal › Article
-
Mark
Akuta vaskulära neurokirurgiska tillstånd kräver snabb hantering
(
- Contribution to journal › Scientific review
-
Mark
Adverse events during endovascular treatment of ruptured aneurysms : A prospective nationwide study on subarachnoid hemorrhage in Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Cerebral Microdialysis-Based Interventions Targeting Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage
(
- Contribution to journal › Article
- 2019
-
Mark
Prediction of Long-Term Outcome After Intracerebral Hemorrhage Surgery
(
- Contribution to journal › Article
-
Mark
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
(
- Contribution to journal › Article
- 2018
-
Mark
Silver-Coated Ventriculostomy Catheters Do Not Reduce Rates of Clinically Diagnosed Ventriculitis
(
- Contribution to journal › Article
-
Mark
Long-term reintegration and quality of life in patients with subarachnoid hemorrhage and a good neurological outcome : Findings after more than 20 years
(
- Contribution to journal › Article